TOOLGEN
DEAD

Serial Number

87379942

Owner

TOOLGEN INCORPORATED

Attorney

Miriam D. Trudell

Filing Date

Mar 21, 2017

Add to watchlist:

No watchlists yet
View on USPTO

TOOLGEN Trademark

Serial Number: 87379942 • Registration: 5578120

TOOLGEN is a trademark filed by TOOLGEN INCORPORATED on March 21, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

TOOLGEN INCORPORATED (7 trademarks)

8th fl.,172, Magokjungang-ro, Gangseo-gu
Seoul . , KR

Entity Type: 03

Trademark Details

Filing Date

March 21, 2017

Registration Date

October 9, 2018

Published for Opposition

July 24, 2018

Cancellation Date

April 25, 2025

Goods & Services

Pharmaceutical and veterinary preparations for the treatment of hereditary diseases; reagents for use in veterinary genetic testing; reagents for use in medical genetic testing; reagents for use in testing genetic mutation in prion genes for medical purposes; stem cells for medical purposes; biotechnological preparations for medical purposes for the treatment of hereditary diseases, namely, pharmaceutical preparations for the treatment of hereditary diseases; cells for medical purposes; diagnostic preparations for medical purposes; cultures of microorganisms for medical purposes; diagnostic preparations for veterinary purposes; biological preparations for medical or veterinary purposes for the treatment of hereditary diseases; surgical implants grown from stem cells; sanitary preparations for medical use

Medical services and health care services relating to DNA, genetics and genetic testing; genetic testing for medical purposes; provision of genetic testing for medical treatment purposes; provision of genetic information for medical treatment purposes; provision of gene therapy for medical treatment purposes; genetic counseling for medical purposes; medical diagnostic services; medical services, namely, physical examination services; performing diagnosis of diseases; medical services relating to the removal, treatment and processing of stem cells; DNA screening for medical purposes; RNA or DNA analysis for cancer diagnosis and prognosis; analysis of human biodata for medical purposes; medical pathology for the diagnosis and treatment of disease; plant nursery services; animal breeding; consultation and providing information in the fields of medicine and health for medical treatment purposes; multiple nucleotide sequence analysis for medical diagnostic purposes; gene analysis for medical diagnostic purposes; stem cell testing for medical treatment, and diagnosis; medical consultation and providing medical information in the field of biomedicine

Scientific consultation and providing scientific information in the field of biomedicine; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; analysis of amino acid for medical research purpose; scientific research in the fields of medicine, health and pharmacology; consultation and providing information in the field of pharmacology; structural and functional analysis of genomes; multiple nucleotide sequence analysis for scientific research purposes; scientific research in the fields of biology; consultation and providing information in the fields of biology; laboratory research in the field of biology; genetic testing for scientific research purposes; gene analysis for scientific research purposes; drug discovery services; protein analysis for scientific research purposes; stem cell testing for medical research purposes; research and development in the pharmaceutical and biotechnology fields; DNA testing for scientific research purposes; DNA analysis for scientific research purposes; DNA sequence analysis for scientific research purposes; DNA screening for scientific research purposes; research and development of DNA chips; biotechnology research; biological research; research and development of new products for others; research on the subject of pharmaceuticals; bacteriological research

Filing History

CANCELLED SEC. 8 (6-YR)
Apr 25, 2025 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 29, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 29, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 29, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 29, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 29, 2023 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 9, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Oct 9, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 24, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jul 24, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 4, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 18, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 18, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 18, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 18, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 18, 2018 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jun 12, 2018 ZZZX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 12, 2018 NPUB
WITHDRAWN FROM PUB - OG REVIEW QUERY
May 30, 2018 PBCR
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 23, 2018 NONP
ELECTRONIC RECORD REVIEW COMPLETE
May 9, 2018 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
May 4, 2018 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
May 1, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 18, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 18, 2018 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 16, 2018 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 1, 2018 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 1, 2018 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 1, 2018 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 27, 2018 RCCK
ASSIGNED TO LIE
Feb 27, 2018 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 14, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 14, 2017 GNSL
SUSPENSION LETTER WRITTEN
Aug 14, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 7, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 7, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 7, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 19, 2017 GNRN
NON-FINAL ACTION E-MAILED
Jun 19, 2017 GNRT
NON-FINAL ACTION WRITTEN
Jun 19, 2017 CNRT
ASSIGNED TO EXAMINER
Jun 14, 2017 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 25, 2017 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 24, 2017 NWOS
NEW APPLICATION ENTERED
Mar 24, 2017 NWAP